TGA, or Therapeutic Goods Administration, is the regulatory authority of Australia for therapeutic goods, including prescription medicines, medical devices, and vaccines, among others. The TGA carries out several assessments along with monitoring activities to make sure that therapeutic goods that are available in the country are of an acceptable standard. The Therapeutic Goods Administration was formed in 1989 under the jurisdiction of Commonwealth of Australia.
What do therapeutic goods include?
A therapeutic good or product is a broad term used for products that are meant to be applied in or on humans for any therapeutic reason. For instance, therapeutic purposes comprise bringing a physiological response for prevention, diagnosis, monitoring, alleviation, cure, or treatment of a disease, defect, ailment, or injury.
What is the role of the TGA?
The TGA monitors the ongoing benefits and risks of therapeutic goods once they are authorised for application. Moreover, the agency can take any action if the benefits are not realised, or additional risks become noticeable.
The probable regulatory measures are distinct from minimal intervention, like labelling modifications, to withdrawing the therapeutic good from the market.